C I Smith|T C Merigan - JoVE Visualize

Showing results (211-220 of 525) with videos related to

Pageof 53

Sort By:

Scandinavian Journal of Immunology|January 1, 1981

Concanavalin-A-induced suppressor lymphocytes in normal individualsC I Smith, A Svejgaard

International Archives of Allergy and Applied Immunology|January 1, 1982

Characterization of human lysozyme (muramidase)-releasing cells. Organ distribution and functional properties as analyzed in a protein A plaque assayC I Smith, L Hammarström

Scandinavian Journal of Immunology|October 1, 1984

Detection of alpha 1 and alpha 2 heavy-chain constant-region genes in common variable hypogammaglobulinaemia patients with undetectable IgAC I Smith, L Hammarström

Scandinavian Journal of Immunology|January 1, 1980

Detection of muramidase (lysozyme)-secreting leucocytes at the single-cell level by a protein A plaque assayC I Smith, L Hammarström

Medical Oncology and Tumor Pharmacotherapy|January 1, 1986

DNA rearrangements in human B- and T-cell malignanciesC I Smith, L Hammarström

Clinical and Experimental Immunology|November 1, 1986

Development of anti-polysaccharide antibodies in asplenic childrenL Hammarström, C I Smith

Journal of Virological Methods|March 1, 1993

Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolatesR W Shafer, M J Kozal, D A Katzenstein, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1982

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combinationS L Sacks, G H Scullard, R B Pollard, et al.

Arthritis and Rheumatism|November 1, 1981

Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune diseaseE G Engleman, G Sonnenfeld, M Dauphinee, et al.

Hepatology (Baltimore, Md.)|January 1, 1982

Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatmentG H Scullard, H B Greenberg, J L Smith, et al.

Pageof 53

Showing results (211-220 of 525) with videos related to

Sort By:

Pageof 53

Scandinavian Journal of Immunology|January 1, 1981

Concanavalin-A-induced suppressor lymphocytes in normal individualsC I Smith, A Svejgaard

International Archives of Allergy and Applied Immunology|January 1, 1982

Characterization of human lysozyme (muramidase)-releasing cells. Organ distribution and functional properties as analyzed in a protein A plaque assayC I Smith, L Hammarström

Scandinavian Journal of Immunology|October 1, 1984

Detection of alpha 1 and alpha 2 heavy-chain constant-region genes in common variable hypogammaglobulinaemia patients with undetectable IgAC I Smith, L Hammarström

Scandinavian Journal of Immunology|January 1, 1980

Detection of muramidase (lysozyme)-secreting leucocytes at the single-cell level by a protein A plaque assayC I Smith, L Hammarström

Medical Oncology and Tumor Pharmacotherapy|January 1, 1986

DNA rearrangements in human B- and T-cell malignanciesC I Smith, L Hammarström

Clinical and Experimental Immunology|November 1, 1986

Development of anti-polysaccharide antibodies in asplenic childrenL Hammarström, C I Smith

Journal of Virological Methods|March 1, 1993

Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolatesR W Shafer, M J Kozal, D A Katzenstein, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1982

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combinationS L Sacks, G H Scullard, R B Pollard, et al.

Arthritis and Rheumatism|November 1, 1981

Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune diseaseE G Engleman, G Sonnenfeld, M Dauphinee, et al.

Hepatology (Baltimore, Md.)|January 1, 1982

Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatmentG H Scullard, H B Greenberg, J L Smith, et al.

Pageof 53